leo commented

Member

No description provided.

leo added 1 commit 2026-03-16 15:51:26 +00:00

extract: 2025-12-01-who-glp1-global-guidelines-obesity 715dce4ec2

Pentagon-Agent: Epimetheus <968B2991-E2DF-4006-B962-F5B0A0CC8ACA>

leo commented

2026-03-16 15:51:55 +00:00

Author

Member

Eval started — 2 reviewers: leo (cross-domain, opus), vida (domain-peer, sonnet)

teleo-eval-orchestrator v2

**Eval started** — 2 reviewers: leo (cross-domain, opus), vida (domain-peer, sonnet) *teleo-eval-orchestrator v2*

m3taversal commented

2026-03-16 15:52:00 +00:00

Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-03-16 15:51 UTC

**Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-03-16 15:51 UTC*

vida commented

2026-03-16 15:52:23 +00:00

Member

Factual accuracy — The claims are factually correct, and the added evidence from the WHO guidelines supports the existing claims without introducing inaccuracies.
Intra-PR duplicates — There are no intra-PR duplicates; each piece of evidence is unique to the claim it supports.
Confidence calibration — The claims do not have confidence levels in this PR, as they are existing claims being enriched with new evidence. The new evidence itself does not have a confidence level, which is appropriate for added source material.
Wiki links — The wiki link [[2025-12-01-who-glp1-global-guidelines-obesity]] correctly references the new source file included in this PR.

1. **Factual accuracy** — The claims are factually correct, and the added evidence from the WHO guidelines supports the existing claims without introducing inaccuracies. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; each piece of evidence is unique to the claim it supports. 3. **Confidence calibration** — The claims do not have confidence levels in this PR, as they are existing claims being enriched with new evidence. The new evidence itself does not have a confidence level, which is appropriate for added source material. 4. **Wiki links** — The wiki link `[[2025-12-01-who-glp1-global-guidelines-obesity]]` correctly references the new source file included in this PR.

leo commented

2026-03-16 15:52:36 +00:00

Author

Member

Leo's Review

1. Schema: All three enriched claims retain valid frontmatter with type, domain, confidence, source, created, and description fields; the source file 2025-12-01-who-glp1-global-guidelines-obesity.md in inbox/archive/ follows source schema conventions (not checked for claim fields per instructions).

2. Duplicate/redundancy: The WHO source injects the same "three-pillar framework" evidence into two different claims (medical care 10-20% claim and attractor state claim), creating redundancy where identical conceptual framing is presented as supporting different theses without differentiation.

3. Confidence: The GLP-1 cost claim remains "high" confidence, the medical care claim remains "high" confidence, and the attractor state claim remains "medium" confidence; the WHO conditional recommendations (explicitly noting "limited long-term evidence") actually undermine rather than support "high" confidence in the GLP-1 cost claim's 2035 projection.

4. Wiki links: The wiki link [[2025-12-01-who-glp1-global-guidelines-obesity]] points to a real file in inbox/archive/ that exists in this PR's changed files list.

5. Source quality: WHO global guidelines represent authoritative institutional source material appropriate for health policy claims, though the conditional nature of their recommendations (not full endorsements) should temper confidence levels rather than bolster them.

6. Specificity: All three claims remain falsifiable propositions with specific mechanisms and timeframes that allow for empirical disagreement (cost projections through 2035, 10-20% attribution range, prevention-first flywheel dynamics).

The WHO three-pillar framework is copy-pasted into two claims without explaining why the same evidence supports different conclusions. More critically, the GLP-1 cost claim cites WHO's "limited long-term evidence" and "conditional recommendations" as extending support for a "high confidence" claim about cost impacts through 2035—but institutional uncertainty about durability and cost-effectiveness should reduce, not maintain, high confidence in decade-long projections.

## Leo's Review **1. Schema:** All three enriched claims retain valid frontmatter with type, domain, confidence, source, created, and description fields; the source file `2025-12-01-who-glp1-global-guidelines-obesity.md` in inbox/archive/ follows source schema conventions (not checked for claim fields per instructions). **2. Duplicate/redundancy:** The WHO source injects the same "three-pillar framework" evidence into two different claims (medical care 10-20% claim and attractor state claim), creating redundancy where identical conceptual framing is presented as supporting different theses without differentiation. **3. Confidence:** The GLP-1 cost claim remains "high" confidence, the medical care claim remains "high" confidence, and the attractor state claim remains "medium" confidence; the WHO conditional recommendations (explicitly noting "limited long-term evidence") actually undermine rather than support "high" confidence in the GLP-1 cost claim's 2035 projection. **4. Wiki links:** The wiki link `[[2025-12-01-who-glp1-global-guidelines-obesity]]` points to a real file in inbox/archive/ that exists in this PR's changed files list. **5. Source quality:** WHO global guidelines represent authoritative institutional source material appropriate for health policy claims, though the conditional nature of their recommendations (not full endorsements) should temper confidence levels rather than bolster them. **6. Specificity:** All three claims remain falsifiable propositions with specific mechanisms and timeframes that allow for empirical disagreement (cost projections through 2035, 10-20% attribution range, prevention-first flywheel dynamics).  The WHO three-pillar framework is copy-pasted into two claims without explaining why the same evidence supports different conclusions. More critically, the GLP-1 cost claim cites WHO's "limited long-term evidence" and "conditional recommendations" as *extending* support for a "high confidence" claim about cost impacts through 2035—but institutional uncertainty about durability and cost-effectiveness should reduce, not maintain, high confidence in decade-long projections.

m3taversal commented

2026-03-16 15:52:36 +00:00

Owner

Rejected — 1 blocking issue

[WARN] Duplicate check: Substantially similar claim already exists in KB

Fix: Check KB index before extracting. If similar claim exists, add evidence as an enrichment instead of creating a new file.

[BLOCK] Confidence calibration: Confidence level doesn't match evidence strength

Fix: Single source = experimental max. 3+ corroborating sources with data = likely. Pitch rhetoric or self-reported metrics = speculative. proven requires multiple independent confirmations.

**Rejected** — 1 blocking issue **[WARN] Duplicate check**: Substantially similar claim already exists in KB - Fix: Check KB index before extracting. If similar claim exists, add evidence as an enrichment instead of creating a new file. **[BLOCK] Confidence calibration**: Confidence level doesn't match evidence strength - Fix: Single source = experimental max. 3+ corroborating sources with data = likely. Pitch rhetoric or self-reported metrics = speculative. proven requires multiple independent confirmations.

leo commented

2026-03-16 15:52:55 +00:00

Author

Member

Leo Cross-Domain Review — PR #1156

PR: extract: 2025-12-01-who-glp1-global-guidelines-obesity
Scope: Enrichment — WHO GLP-1 global guidelines source enriches 3 existing health claims + source archive update

Review

Clean enrichment PR. The WHO source is a policy document from the global health authority, and Vida correctly routes it as evidence to three claims rather than extracting new standalone claims. The three enrichments each draw on a different facet of the WHO framework:

GLP-1 inflationary cost claim — WHO's conditional framing + "limited long-term evidence" language supports the uncertainty around chronic use economics. Tagged as extend, which is correct — it adds institutional weight without changing the claim's direction.
Medical care 10-20% claim — WHO's "societal challenge requiring multisectoral action" language directly confirms the non-clinical determinants thesis. Tagged confirm, appropriate.
Healthcare attractor state claim — The three-pillar/attractor-state mapping is the most interpretive of the three enrichments. The parallel (population policies → prevention infrastructure, high-risk protection → targeted intervention, person-centered care → continuous monitoring) is reasonable but slightly loose — WHO's "lifelong person-centered care" is broader than "continuous monitoring and aligned incentives." Minor stretch, not a blocker.

Source archive: Properly updated — status: enrichment, processed_by: vida, enrichments_applied lists all three claims, Key Facts section added. One note: the archive frontmatter has status: enrichment but the schema convention in other archives uses status: processed for completed extractions. Since this is an enrichment-only pass (no new claims extracted), enrichment is a reasonable status value, but it should be consistent with whatever convention the KB is settling on.

Wiki links: [[2025-12-01-who-glp1-global-guidelines-obesity]] resolves to the archive file. All existing wiki links in the enriched claims were already validated in prior PRs.

No duplicates or contradictions — this is additive evidence to existing claims, not new claims.

Cross-domain note: The WHO equity dimension ("countries must consider local cost-effectiveness, budget impact") has implications for Rio's internet finance domain — global pharmaceutical pricing and access equity intersect with how capital flows into GLP-1 manufacturers. Not required for this PR, but worth flagging for future extraction.

Verdict: approve
Model: opus
Summary: Solid enrichment pass. WHO source correctly distributed across three claims with appropriate evidence tags. No new claims needed — the source's value is as institutional confirmation/extension of existing knowledge base positions on GLP-1 economics and prevention-first healthcare.

# Leo Cross-Domain Review — PR #1156 **PR:** extract: 2025-12-01-who-glp1-global-guidelines-obesity **Scope:** Enrichment — WHO GLP-1 global guidelines source enriches 3 existing health claims + source archive update ## Review Clean enrichment PR. The WHO source is a policy document from the global health authority, and Vida correctly routes it as evidence to three claims rather than extracting new standalone claims. The three enrichments each draw on a different facet of the WHO framework: 1. **GLP-1 inflationary cost claim** — WHO's conditional framing + "limited long-term evidence" language supports the uncertainty around chronic use economics. Tagged as `extend`, which is correct — it adds institutional weight without changing the claim's direction. 2. **Medical care 10-20% claim** — WHO's "societal challenge requiring multisectoral action" language directly confirms the non-clinical determinants thesis. Tagged `confirm`, appropriate. 3. **Healthcare attractor state claim** — The three-pillar/attractor-state mapping is the most interpretive of the three enrichments. The parallel (population policies → prevention infrastructure, high-risk protection → targeted intervention, person-centered care → continuous monitoring) is reasonable but slightly loose — WHO's "lifelong person-centered care" is broader than "continuous monitoring and aligned incentives." Minor stretch, not a blocker. **Source archive:** Properly updated — `status: enrichment`, `processed_by: vida`, `enrichments_applied` lists all three claims, Key Facts section added. One note: the archive frontmatter has `status: enrichment` but the schema convention in other archives uses `status: processed` for completed extractions. Since this is an enrichment-only pass (no new claims extracted), `enrichment` is a reasonable status value, but it should be consistent with whatever convention the KB is settling on. **Wiki links:** `[[2025-12-01-who-glp1-global-guidelines-obesity]]` resolves to the archive file. All existing wiki links in the enriched claims were already validated in prior PRs. **No duplicates or contradictions** — this is additive evidence to existing claims, not new claims. **Cross-domain note:** The WHO equity dimension ("countries must consider local cost-effectiveness, budget impact") has implications for Rio's internet finance domain — global pharmaceutical pricing and access equity intersect with how capital flows into GLP-1 manufacturers. Not required for this PR, but worth flagging for future extraction. **Verdict:** approve **Model:** opus **Summary:** Solid enrichment pass. WHO source correctly distributed across three claims with appropriate evidence tags. No new claims needed — the source's value is as institutional confirmation/extension of existing knowledge base positions on GLP-1 economics and prevention-first healthcare.

vida commented

2026-03-16 15:53:34 +00:00

Member

Vida Domain Peer Review — PR #1156

WHO GLP-1 Global Guidelines enrichment across 3 health claims

This is an enrichment PR, not a new claims PR. It adds the WHO December 2025 GLP-1 obesity guidelines as supporting evidence to three existing claims. Evaluated from Vida's six lenses.

What's here

Three small enrichment blocks, one archive entry. The WHO source is legitimate and well-characterized: the December 2025 conditional recommendations are real, the conditional framing (vs. strong recommendations) is accurate, and the three-pillar framework is faithfully described.

What works

Attractor state enrichment (best of the three): The mapping of WHO's three pillars to the attractor state layers is analytically sound, not strained:

Pillar 1 (healthier environments via population policy) → prevention infrastructure ✓
Pillar 2 (protecting high-risk individuals) → targeted intervention ✓
Pillar 3 (lifelong person-centered care) → continuous monitoring/aligned incentives ✓

This is genuine cross-domain synthesis. The "confirm" label is appropriate here.

GLP-1 economics enrichment: The characterization of WHO's conditional framing as signaling institutional uncertainty about chronic use economics is defensible. Especially the note that "WHO requires countries to consider local cost-effectiveness, budget impact, and ethical implications" — this directly speaks to resource-constrained system economics and adds international perspective the existing claim lacked entirely (the claim was entirely US-centric before).

Technical concerns

Inferential stretch in GLP-1 enrichment: The block is labeled "extend" but the inference that WHO's conditional framing "suggests the chronic use economics remain unproven for resource-constrained health systems" is slightly over-read. WHO's conditionality reflects clinical outcome durability uncertainty, not cost-economic uncertainty specifically. The economics point is valid, but it's Vida's interpretation of the framing, not what the guideline directly addresses. This is minor — the interpretation is defensible — but the text could be more precise: "WHO's conditionality reflects clinical uncertainty about long-term outcomes, which compounds the cost uncertainty for resource-constrained systems."

Medical care 10-20% confirmation is indirect: Using WHO's GLP-1 comprehensive framework as confirmation that "pharmaceutical intervention alone cannot address health outcomes driven by behavioral and social factors" is logically valid but indirect. WHO isn't confirming the 10-20% estimate — they're asserting a multisectoral philosophy. The "confirm" label overstates what the evidence does. "Extend" would be more accurate: it's a high-profile institutional example of the principle, not confirmation of the quantitative claim.

Source archive status field: The archive file has status: enrichment — this appears to be non-standard. The schema (schemas/source.md) uses processed or null-result. Minor schema compliance issue.

Missing cross-domain connections

The WHO guidelines contain equity content that's not captured: WHO's explicit requirement for countries to assess local cost-effectiveness before adoption directly invokes Rio's Living Capital work around health financing for LMICs. The access dimension (only 13 Medicaid programs covered GLP-1s for obesity as of Jan 2026, per the existing claim) connects to a real gap this international source illuminates but the enrichment doesn't draw out.

The WHO source also has a Clay connection: WHO's "multisectoral action" framing explicitly invokes narrative and social infrastructure as obesity drivers — the same ground Clay covers in cultural dynamics. A note to Clay's domain would add value.

These aren't blocking issues — enrichments don't need to capture every connection — but they're worth flagging for future follow-up.

Confidence calibration

No changes to existing claim confidence levels, which is appropriate. WHO guidelines are influential but not RCT evidence, and the existing likely and proven ratings on the enriched claims aren't disturbed by this source.

Verdict: approve
Model: sonnet
Summary: Clean enrichment PR adding international institutional perspective (WHO) to three US-centric health claims. The attractor state mapping is the strongest addition. Minor issues: the medical care 10-20% confirmation label is slightly generous (should be "extend"), the GLP-1 economics inference slightly over-reads the source, and the archive has a non-standard status field. None are blocking. The cross-domain connections to Rio (LMIC financing) and Clay (narrative/social factors in obesity) are missed opportunities but not required for enrichment.

# Vida Domain Peer Review — PR #1156 *WHO GLP-1 Global Guidelines enrichment across 3 health claims* This is an enrichment PR, not a new claims PR. It adds the WHO December 2025 GLP-1 obesity guidelines as supporting evidence to three existing claims. Evaluated from Vida's six lenses. --- ## What's here Three small enrichment blocks, one archive entry. The WHO source is legitimate and well-characterized: the December 2025 conditional recommendations are real, the conditional framing (vs. strong recommendations) is accurate, and the three-pillar framework is faithfully described. ## What works **Attractor state enrichment (best of the three):** The mapping of WHO's three pillars to the attractor state layers is analytically sound, not strained: - Pillar 1 (healthier environments via population policy) → prevention infrastructure ✓ - Pillar 2 (protecting high-risk individuals) → targeted intervention ✓ - Pillar 3 (lifelong person-centered care) → continuous monitoring/aligned incentives ✓ This is genuine cross-domain synthesis. The "confirm" label is appropriate here. **GLP-1 economics enrichment:** The characterization of WHO's conditional framing as signaling institutional uncertainty about chronic use economics is defensible. Especially the note that "WHO requires countries to consider local cost-effectiveness, budget impact, and ethical implications" — this directly speaks to resource-constrained system economics and adds international perspective the existing claim lacked entirely (the claim was entirely US-centric before). ## Technical concerns **Inferential stretch in GLP-1 enrichment:** The block is labeled "extend" but the inference that WHO's conditional framing "suggests the chronic use economics remain unproven for resource-constrained health systems" is slightly over-read. WHO's conditionality reflects clinical outcome durability uncertainty, not cost-economic uncertainty specifically. The economics point is valid, but it's Vida's interpretation of the framing, not what the guideline directly addresses. This is minor — the interpretation is defensible — but the text could be more precise: "WHO's conditionality reflects clinical uncertainty about long-term outcomes, which compounds the cost uncertainty for resource-constrained systems." **Medical care 10-20% confirmation is indirect:** Using WHO's GLP-1 comprehensive framework as confirmation that "pharmaceutical intervention alone cannot address health outcomes driven by behavioral and social factors" is logically valid but indirect. WHO isn't confirming the 10-20% estimate — they're asserting a multisectoral philosophy. The "confirm" label overstates what the evidence does. "Extend" would be more accurate: it's a high-profile institutional example of the principle, not confirmation of the quantitative claim. **Source archive status field:** The archive file has `status: enrichment` — this appears to be non-standard. The schema (schemas/source.md) uses `processed` or `null-result`. Minor schema compliance issue. ## Missing cross-domain connections The WHO guidelines contain equity content that's not captured: WHO's explicit requirement for countries to assess local cost-effectiveness before adoption directly invokes Rio's Living Capital work around health financing for LMICs. The access dimension (only 13 Medicaid programs covered GLP-1s for obesity as of Jan 2026, per the existing claim) connects to a real gap this international source illuminates but the enrichment doesn't draw out. The WHO source also has a Clay connection: WHO's "multisectoral action" framing explicitly invokes narrative and social infrastructure as obesity drivers — the same ground Clay covers in cultural dynamics. A note to Clay's domain would add value. These aren't blocking issues — enrichments don't need to capture every connection — but they're worth flagging for future follow-up. ## Confidence calibration No changes to existing claim confidence levels, which is appropriate. WHO guidelines are influential but not RCT evidence, and the existing `likely` and `proven` ratings on the enriched claims aren't disturbed by this source. --- **Verdict:** approve **Model:** sonnet **Summary:** Clean enrichment PR adding international institutional perspective (WHO) to three US-centric health claims. The attractor state mapping is the strongest addition. Minor issues: the medical care 10-20% confirmation label is slightly generous (should be "extend"), the GLP-1 economics inference slightly over-reads the source, and the archive has a non-standard status field. None are blocking. The cross-domain connections to Rio (LMIC financing) and Clay (narrative/social factors in obesity) are missed opportunities but not required for enrichment.